What’s on the Horizon for Keratoconus?
The number of keratoconus treatment options is growing, with new techniques and devices in development.
In a recent article, Review of Ophthalmology examines how advances in corneal cross-linking are reshaping the future of keratoconus management. The piece highlights the development of minimally invasive epithelium-on cross-linking technologies, including Epion Therapeutics’ EpiSmart system – currently under evaluation in Phase 3 FDA clinical trials – reflecting a broader shift toward earlier and safer intervention across a wide range of patients.